Yang Sui

CD52 is a prognostic biomarker and correlated with immune features in breast cancer

Jie Tian, Changjun Wu, Lin Tao, 2020 .

A deep learning model for early risk prediction of heart failure with preserved ejection fraction by DNA methylation profiles combined with clinical features

K. He, H. Qu, W. Dong, 2022, Clinical Epigenetics.

GliomaDB: A Web Server for Integrating Glioma Omics Data and Interactive Analysis

Bingbing Xie, Yadong Yang, Xiangdong Fang, 2019, Genom. Proteom. Bioinform..

Development and validation of a hypoxia-related prognostic signature for breast cancer

Changjun Wu, Qianqi Liu, P. Xing, 2020, Oncology letters.

CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer

Hailin Tang, Changjun Wu, Guangchen Zhang, 2020, Frontiers in Genetics.